Trials / Conditions / Melanoma Stage IIIB-IV
Melanoma Stage IIIB-IV
3 registered clinical trials studyying Melanoma Stage IIIB-IV — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma NCT06624644 | Linnaeus Therapeutics, Inc. | Phase 2 / Phase 3 |
| Recruiting | NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma NCT06651151 | Oslo University Hospital | Phase 2 |
| Unknown | Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma NCT04248387 | Fudan University | Phase 2 |